Skip to main content

Table 1 Comparison of biological and treatment parameters between the 3 periods

From: Online-haemodiafiltration vs. conventional haemodialysis: a cross-over study

 

HDF1

HD

HDF2

Albumin (g/l)

34.4 ± 3

35.9 ± 3**

34.1 ± 4

ß2-microglobumin (mg/l)

26.1 ± 5

28 ± 6*

26.5 ± 5

Calcaemia (mmol/l)

2.2 ± 0.1

2.19 ± 0.1

2.18 ± 0.1

Phosphataemia (mmol/l)

1.58 ± 0.2

1.59 ± 0.3

1.61 ± 0.2

iPTH (pg/ml)

215 ± 110

220 ± 111

245 ± 108

Kt/V

1.67 ± 0,2

1.71 ± 0.25

1.74 ± 0.25

nPCR (g/kg/d)

1 ± 0.1

1.08 ± 0,19

1.05 ± 0,19

CRP mg/l

7.5 ± 9

7 ± 8

7.7 ± 8

Hb (g/dl)

11.7 ± 1

11.8 ± 0.8

11.7 ± 0.7

BNP (pg/ml)

445 ± 478

398 ± 466

408 ± 485

sBP/dBP (mmHg)

133/61 ± 17/11

132/59 ± 18/11

134/61 ± 18/11

Dry body weight [37]

72.6 ± 11

72 ± 12

72.1 ± 12

Interdialytic weight gain [37]

1.8 ± 0.6

2 ± 0.6

2 ± 0.7

BCM OH-post (Litre)

−0.96 ± 1.4

−1.01 ± 1.5

−1.06 ± 1.5

Dialysate calcium (mmol/L)

1.51 ± 0.2

1.56 ± 0.2

1.54 ± 0.17

Blood flow rate (m/min)

330 ± 30

328 ± 27

329 ± 26

Dialysate Flow rate (mL/min)

500

500

500

Convection volume (Litre)

22.2 ± 3.3

0

21 ± 3.1

Hypotension/ cramps (% session)

15.7

12

20

Antihypertensive medications unit/day (%)

1.2 ± 0.4 (37.3)

1.2 ± 0.4 (37.3)

1.2 ± 0.4 (37.3)

ESA U/week

5000 ± 4000

4660 ± 3500

4900 ± 3500

Alfacalcidol μg/week (%)

2.2 ± 1 (37)

2.1 ± 1 (37)

2.1 ± 1 (35)

Calcium unit/d (%)

1.9 ± 2 (48)

1.88 ± 2.2 (50)

1.9 ± 2.2 (48)

Cinacalcet mg/d (%)

52 (5.8)

52 (5.8)

47 (7.8)

Sevelamer unit/d (%)

3.3 ± 4 (31)

3.4 ± 4 (33)

4 ± 4 (33)

  1. *p < 0.001, **p < 0.0001 vs. other periods (ANOVA)